Hong Kong
· Delayed Price · Currency is HKD Hansoh Pharmaceutical Group Company Company Description
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
The company provides products for therapeutic areas, including anti-tumor, anti-infection, central nervous system diseases, oncology, metabolic and autoimmune diseases, etc. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Hengmu, Mailingda, Hengsen, XINYUE, Saint Luolai, Fulaimei, Pulaitan, Tanneng, Ameining, Oulanning, Ruibote, Fulaidi, Fulairui, and Puruian tablets.
The company serves pharmaceutical product distributors. It has licence agreements with GSK plc to develop, manufacture, and commercialise HS20089 and HS-20093; GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089; and Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product, as well as collaboration agreement with Antengene Corporation Limited to commercialize selinexor and any product containing or comprising Selinexor.
In addition, it engages in trading business. The company was founded in 1995 and is headquartered in Shanghai, the People’s Republic of China.
Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9,123 |
| CEO | Huijuan Zhong |
Contact Details
Address: 287 Xiangke Road Shanghai, 201210 China | |
| Phone | 86 40 0828 5227 |
| Website | hspharm.com |
Stock Details
| Ticker Symbol | 3692 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG549581067 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Huijuan Zhong | Chairlady, Chief Executive Officer and President |
| Dr. Aifeng Lyu | Executive Director |
| Yuan Sun | Executive Director |
| Min Hu | Vice President and Chief Financial Officer |
| Dr. Chih-Hung Lee | Chief of Science Officer |
| Chuanhe Xu | Senior Vice President |
| Weiyong Sun | Chief Commercial Officer |
| Shengli Zhong | Joint Company Secretary and Senior Vice President |
| Sze Wai Tam | Joint Company Secretary |